Phase 3 clinical trial will evaluate aglatimagene besadenovec plus valacyclovir in combination with continued pembrolizumab versus standard-of-care docetaxel chemotherapy in patie ...
The FDA has granted Fast Track designation to BM-3103, a novel topical mTOR inhibitor for epidermolysis bullosa simplex currently in phase 2.
SHELTON, CT / ACCESS Newswire / July 6, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical ...
"With a Phase 2a asset in HSV and an EBV program approaching clinical readiness, Innovative Molecules is uniquely positioned as a leading developer of next-generation therapies targeting herpesviruses ...
Lead candidate BM-3103 (TolaSure® Gel™) now holds Fast Track, Orphan Drug, and Rare Pediatric Disease designations as BioMendics advances the TAMES-02 Phase 2 study (NCT07027345). AKRON, ...
Lead candidate BM-3103 (TolaSure® Gel™) now holds Fast Track, Orphan Drug, and Rare Pediatric Disease designations as BioMendics advances the TAMES-02 Phase 2 study (NCT07027345). BioMendics, LLC, a ...
Innovative Molecules GmbH, a late-stage clinical biotechnology company focused on the development of differentiated antiviral therapies, today announced that the first patient has ...
Infamous celebrities Lindsay Lohan and Charlie Sheen seemed to be a perfect pair in "Scary Movie 5." Reportedly, the stars ...
Onlymyhealth on MSN
Is Herpes a Lifelong STD? A Gynaecologist Explains If It Stays in Your Body Forever
Herpes is one of the most common sexually transmitted infections, yet it's surrounded by confusion and misinformation. Many ...
AKRON, Ohio, June 23, 2026--(BUSINESS WIRE)--BioMendics, LLC, a clinical-stage biotechnology company developing innovative therapies for rare genetic skin disorders, today announced that the U.S. Food ...
If the US FDA approves it, aglatimagene immunotherapy may become the first new therapy for men with localized prostate cancer in the past 2 decades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results